A novel conditioning regimen with pre-transplantation immunosuppression reduces the complication rates in hematopoietic stem cell transplantation in transfusion-dependent β-thalassemia
Stem Cell Res Ther. 2024 Dec 21;15(1):495. doi: 10.1186/s13287-024-04103-6. ABSTRACT BACKGROUND: Allo-HSCT is a curative therapy for patients with transfusion-dependent thalassemia (TDT). The high incidence …